drugset / Trial / NCT00092300

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

NCT00092300

Phase 3 Completed 450 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Timeline

Start
2002-05
Primary completion
2002-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject rofecoxib Small molecule 50 mg
Subject valdecoxib Small molecule 20 mg

Indications

No indication recorded.